SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the first quarter ended March 31, 2024 and provided a business update. The post Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update appeared first on Bio Tech Winners ..read more

SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial results for the fourth quarter and full fiscal year 2024 (FY2024) after the market closes on Thursday, May 23, 2024. The Company will webcast a conference call at 4:30 p.m. Eastern Time on that date to discuss the quarter and year’s financial results and report on business progress. The post 23andMe to Repo ..read more

Montrouge, France, le 9 mai The post Participation de DBV Technologies aux conférences investisseurs en mai appeared first on Bio Tech Winners ..read more

Montrouge, France, May 9, 2024 The post DBV Technologies to Participate in Upcoming Investor Conferences appeared first on Bio Tech Winners ..read more

Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates The post Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates appeared first on Bio Tech Winners ..read more

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update The post Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update appeared first on Bio Tech Winners ..read more

Company to Host Conference Call Today, May 9, at 4:30pm ET Company to Host Conference Call Today, May 9, at 4:30pm ET The post INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update appeared first on Bio Tech Winners ..read more

Senti Biosciences, Inc. (Nasdaq: SNTI) today reported operational updates and financial results for the first quarter of 2024. The post Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights appeared first on Bio Tech Winners ..read more

MALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions today reported financial results for the first quarter ended March 31, 2024. The post TELA Bio Reports First Quarter 2024 Financial Results appeared first on Bio Tech Winners ..read more

PRESS RELEASE The post Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting appeared first on Bio Tech Winners ..read more